Skip to main content
Premium Trial:

Request an Annual Quote

Ariosa Signs UK Distribution Deal for Harmony Prenatal Test; Plans to Expand Indications

NEW YORK (GenomeWeb News) — Ariosa Diagnostics said today that it is partnering with the Doctors Laboratory to distribute its Harmony Prenatal Test in the UK.

Under the terms of the agreement, the Doctors Laboratory, a clinical pathology testing services organization, will offer the Harmony test to doctors and their pregnant patients. The Doctors Laboratory is based in London with smaller laboratories positioned throughout the UK.

Separately, Ariosa said that it plans to expand the indications for the Harmony test, which analyzes cell-free DNA circulating in maternal blood in order to detect fetal trisomies.

The company said that it will expand the test's indications to include all in vitro fertilization singleton pregnancies, including unrelated egg donor and surrogate pregnancies, but did not provide a timeline for the launch of the expanded test.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.